Skip to main content

Advertisement

Table 1 Histologic subtype of ovarian cancer patients who visited the HCP for BRCA mutation testing before and after the educational campaign

From: A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

  BRCA mutation tested (n = 887) BRCA positive (n = 163)
Histologic subtype, n (%) Before the campaign After the campaign Total Before the campaign After the campaign Total
Serous 270 (59.0) 311 (72.5) 581 (65.5) 76 (73.8) 48 (79.7) 124 (75.6)
Endometrioid 60 (13.1) 29 (6.8) 89 (10.0) 5 (4.9) < 3% a < 5%a
Clear cell 31 (6.8) 15 (3.5) 46 (5.2) < 4%a < 3%a < 5%a
Unknown 95 (20.7) 71 (16.6) 166 (18.7) 19 (18.5) 10 (16.4) 29 (17.7)
p-value    < 0.001    0.519
  1. aSuppressed due to small cell sizes so approximate percentages have been reported Mucinous cancer was excluded from this table due to privacy concerns around small cell sizes